Mecapegfilgrastim Injection

DRUG3 trials

Sponsors

Xiaohua Wu MD, Affiliated Hospital of Nantong University, Hebei Medical University Fourth Hospital

Conditions

ChemoradiotherapyGynecologic Malignant TumorMyelosuppressionNeutropeniaThoracic Neoplasms

Phase 2

Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy

RecruitingNCT07205536

Affiliated Hospital of Nantong UniversityChemoradiotherapy, Myelosuppression, Thoracic Neoplasms

Start: 2025-08-01End: 2027-12-31Target: 30Updated: 2025-12-11

Unknown Phase

Efficacy and Safety of PEG-rhG-CSF in the Prevention of Neutropenia After Chemo in Pts With Gynecological Malignancies

Xiaohua Wu MDGynecologic Malignant Tumor

Start: 2021-05-31End: 2022-08-31Target: 150Updated: 2021-02-26

Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection

RecruitingNCT07434063

Hebei Medical University Fourth HospitalNeutropenia

Start: 2025-06-18End: 2027-06-30Target: 200Updated: 2026-02-25